Skip to content

Comparison of the Efficacy and Safety of Tegileridine and Sufentanil for Postoperative Analgesia After Complex Anal Fistula Surgery: A Randomized Controlled Trial

Comparison of the Efficacy and Safety of Tegileridine and Sufentanil for Postoperative Analgesia After Complex Anal Fistula Surgery: A Randomized Controlled Trial

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600129908
Enrollment
Unknown
Registered
2026-08-11
Start date
2026-08-31
Completion date
Unknown
Last updated
2026-08-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

postoperative pain

Interventions

Sponsors

LONGHUA Hospital Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Age between 18 and 65 years (inclusive); 2. American Society of Anesthesiologists (ASA) physical status classification I-II; 3. Patients scheduled for elective complex anal fistula resection under spinal anesthesia; 4. No history of chronic pain; 5. Normal function of major organs and normal coagulation function; 6. Subjects voluntarily participate in the study and provide written informed consent.

Exclusion criteria

Exclusion criteria: 1. Allergy to the investigational drug or a history of drug dependence/abuse; 2. Severe hepatic or renal dysfunction (ALT/AST > 2 times the upper limit of normal [ULN], or creatinine clearance < 60 mL/min); 3. Severe cardiovascular disease; 4. Pregnancy or breastfeeding; 5. Psychiatric disorders or cognitive impairment; 6. Use of potent opioid analgesics within 1 week before surgery; 7. Use of antibiotics within 1 week before surgery; 8. Patients who are considered by the investigator to be unsuitable for participation in this study for other reasons.

Design outcomes

Primary

MeasureTime frame
The 24-hour resting pain intensity difference time-weighted sum after administration (rSPID24);

Secondary

MeasureTime frame
Hemodynamics: Blood Pressure and Heart Rate;Postoperative pain relief parameters: total amount of pain relief (TOTPAR) and the number of effective PCA presses within 24 hours;

Countries

China

Contacts

Public ContactPeng Sheng

LONGHUA Hospital Shanghai University of Traditional Chinese Medicine

ps7707@163.com+86 21 6438 5700

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Sep 19, 2026